<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Zurflüh MR</dc:creator>
  <dc:creator>Zschocke J</dc:creator>
  <dc:creator>Lindner M</dc:creator>
  <dc:creator>Feillet F</dc:creator>
  <dc:creator>Chery C</dc:creator>
  <dc:creator>Burlina A</dc:creator>
  <dc:creator>Stevens RC</dc:creator>
  <dc:creator>Thöny B</dc:creator>
  <dc:creator>Blau N</dc:creator>
  <dc:date>2008</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Mutations in the phenylalanine hydroxylase (PAH) gene result in phenylketonuria (PKU). Tetrahydrobiopterin (BH(4))-responsive hyperphenylalaninemia has been recently described as a variant of PAH deficiency caused by specific mutations in the PAH gene. It has been suggested that BH(4)-responsiveness may be predicted from the corresponding genotypes. Data from BH(4) loading tests indicated an incidence of BH(4)-responsiveness of &gt;40% in the general PKU population and &gt;80% in mild PKU patients. The current project entailed genotype analysis of 315 BH(4)-responsive patients tabulated in the BIOPKUdb database and comparison with the data from the PAHdb locus-specific knowledgebase, as well as with previously published PAH mutations for several European countries, Northern China, and South Korea. We identified 57 mutations, presenting with a substantial residual PAH activity (average approximately 47%), presumed to be associated with BH(4)-responsiveness. More than 89% of patients are found to be compound heterozygotes. The three most common mutations found in &gt;5% of BH(4)-responsive patients are p.A403 V, p.R261Q, and p.Y414C. Using the Hardy-Weinberg formula the predicted average frequency of BH(4)-responsiveness in European populations was calculated to be 55% (range 17-79%, lowest in Baltic countries and Poland and highest in Spain), 57% in Northern China, and 55% for South Korea. The genotype-predicted prevalence of BH(4)-responsiveness was higher than prevalence data obtained from BH(4) loading tests. Inconsistent results were observed for mutations p.L48S, p.I65 T, p.R158Q, p.R261Q, and p.Y414C. Our data suggest that BH(4)-responsiveness may be more common than assumed and to some extent may be predicted or excluded from the patient's genotype.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/219430</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1002/humu.20637</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/17935162</dc:relation>
  <dc:source>Human mutation. - 2008</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Biopterin</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">China</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Europe</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Gene Expression Regulation, Enzymologic</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Gene Frequency</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Genetics, Population</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Genotype</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Korea</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Models, Molecular</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Mutation</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Phenylalanine Hydroxylase</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Phenylketonurias</dc:subject>
  <dc:title xmlns:ns14="xml" ns14:lang="en">Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
